Barry Freedman to Receptors, Urokinase Plasminogen Activator
This is a "connection" page, showing publications Barry Freedman has written about Receptors, Urokinase Plasminogen Activator.
Connection Strength
1.357
-
Hayek SS, Divers J, Raad M, Xu J, Bowden DW, Tracy M, Reiser J, Freedman BI. Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High-Sensitivity C-Reactive Protein. J Am Heart Assoc. 2018 05 01; 7(9).
Score: 0.653
-
Skorecki KL, Freedman BI. A suPAR Biomarker for Chronic Kidney Disease. N Engl J Med. 2015 Nov 12; 373(20):1971-2.
Score: 0.550
-
Hayek SS, Koh KH, Grams ME, Wei C, Ko YA, Li J, Samelko B, Lee H, Dande RR, Lee HW, Hahm E, Peev V, Tracy M, Tardi NJ, Gupta V, Altintas MM, Garborcauskas G, Stojanovic N, Winkler CA, Lipkowitz MS, Tin A, Inker LA, Levey AS, Zeier M, Freedman BI, Kopp JB, Skorecki K, Coresh J, Quyyumi AA, Sever S, Reiser J. A tripartite complex of suPAR, APOL1 risk variants and avß3 integrin on podocytes mediates chronic kidney disease. Nat Med. 2017 Aug; 23(8):945-953.
Score: 0.154